DC9191 |
Metoprolol tartrate |
Metoprolol is a cardioselective β1-adrenergic blocking agent. |
|
DC9110 |
Mevastatin |
Mevastatin (Compactin; ML236B) inhibits HMGCR (HMG-CoA reductase) (Ki for acid form is 1 nM) which in turn inhibits isoprenoid biosynthesis and therefore blocks protein isoprenylation and reduces plasma cholesterol levels in humans. |
|
DC8974 |
Mexiletine Hydrochloride
Featured
|
Mexiletine hydrochloride is a non-selective voltage-gated sodium channel blocker; Class IB anti-arrhythmic compound. |
|
DCAPI1324 |
Miglitol (Glyset) |
Miglitol (Glyset) |
|
DCAPI1436 |
Milbemycin oxime
Featured
|
Milbemycin oxime is a semi-synthetic macrocyclic lactone prepared by the oxidation and oximation of a mixture of two natural products, milbemycin A3 and A4 (in ~70: 30 ratio). Moxidectin oxime, marketed as Interceptor, is used therapeutically for the prev |
|
DCAPI1003 |
Milnacipran HCl |
Milnacipran inhibits both norepinephrine transporter (NET) and norepinephrine transporter (SERT) with IC50 of 77 nM and 420 nM, respectively. |
|
DC8968 |
Minoxidil |
Minoxidil(U 10858) is an antihypertensive vasodilator medication. |
|
DCAPI1458 |
Miriplatin |
Miriplatin |
|
DCAPI1370 |
Mirtazapine (Remeron, Avanza) |
Mirtazapine (Remeron, Avanza) |
|
DCAPI1234 |
Mitotane (Lysodren) |
Mitotane (Lysodren) |
|
DCAPI1315 |
Mitoxantrone HCl |
Mitoxantrone HCl |
|
DCAPI1029 |
Moguisteine
Featured
|
Moguisteine is a novel peripheral non-narcotic antitussive drug. |
|
DC8991 |
Molsidomine |
Molsidomine is an orally active, long acting vasodilating drug, metabolized in the liver to the active metabolite linsidomine, which is an unstable compound that releases nitric oxide (NO) upon decay as the actual vasodilating compound. |
|
DCAPI1363 |
Mometasone furoate |
Mometasone furoate |
|
DCAPI1006 |
Monobenzone (Benoquin) |
Monobenzone (Benoquin) |
|
DCAPI1331 |
Moxonidine |
Moxonidine |
|
DCAPI1572 |
Moxonidine hydrochloride |
Moxonidine hydrochloride |
|
DC9138 |
Mycophenolate Mofetil |
Mycophenolate mofetil is a prodrug for mycophenolic acid, a potent inhibitor of inosine monophosphate dehydrogenase (IC50 = 11 nM). Inhibition of this enzyme blocks de novo GTP generation as well as RNA and DNA synthesis in lymphocytes. In this way, mycop |
|
DCAPI1127 |
Mycophenolic (Mycophenolate) |
Mycophenolic (Mycophenolate) |
|
DC8980 |
Nabumetone |
Nabumetone(BRL14777) is a non-steroidal anti-inflammatory drug and its active metabolite inhibits the COX. |
|
DCAPI1550 |
Naftopidil |
Naftopidil is an α-1-Adrenergic receptor antagonist and an antihypertensive. |
|
DCAPI1173 |
Nalidixic acid (NegGram) |
Nalidixic acid (NegGram) |
|
DCAPI1293 |
Nanchangmycin |
Nanchangmycin (dianemycin) is a polyether antibiotic with similar structure to dianemycin and is very active against a broad spectrum of harmful nematodes and insects but not for for mammals and plants. |
|
DCAPI1368 |
Naphyrone (O-2482) |
Naphyrone (O-2482) |
|
DC9000 |
Naproxen sodium |
Naproxen is a COX inhibitor for COX-1 and COX-2 with IC50 of 8.7 μM and 5.2 μM, respectively. |
|
DC8982 |
Naproxen |
Naproxen is a COX inhibitor for COX-1 and COX-2 with IC50 of 8.7 μM and 5.2 μM, respectively. |
|
DCAPI1460 |
Naratriptan hydrochloride |
Naratriptan Hydrochloride is a triptan drug which is used for the treatment of migraine headaches. |
|
DCAPI1337 |
Natamycin(Pimaricin) |
Natamycin(Pimaricin) |
|
DC9063 |
Nateglinide |
Nateglinide is an insulin secretagog agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). |
|
DCAPI1056 |
Nattokinase
Featured
|
Nattokinase, Natto fermentation is a potent fibrinolytic enzyme. Nattokinase can break down blood clots by directly hydrolyzing fibrin and plasmin substrate. Nattokinase can be used for the research of cardiovascular diseases. |
|